HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanku Mallik Selected Research

N-end cysteine peptide tumor-homing peptide

1/2022Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells.
1/2021Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
3/2018Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sanku Mallik Research Topics

Disease

34Neoplasms (Cancer)
02/2022 - 10/2004
18Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 01/2012
9Hypoxia (Hypoxemia)
01/2022 - 01/2016
6Breast Neoplasms (Breast Cancer)
10/2021 - 12/2012
6Prostatic Neoplasms (Prostate Cancer)
06/2021 - 09/2009
2Triple Negative Breast Neoplasms
01/2022 - 09/2021
2Neoplasm Metastasis (Metastasis)
01/2016 - 09/2012
1Cardiotoxicity
12/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Adenocarcinoma
01/2019
1Neuroblastoma
03/2015
1Pancreatic Ductal Carcinoma
11/2014
1Noninfiltrating Intraductal Carcinoma (DCIS)
04/2014
1T-Cell Lymphoma (Lymphoma, T Cell)
11/2013
1Disease Progression
10/2013
1Rupture
09/2012
1Atherosclerotic Plaque (Atheroma)
09/2012
1Alzheimer Disease (Alzheimer's Disease)
08/2011

Drug/Important Bio-Agent (IBA)

23Pharmaceutical PreparationsIBA
01/2022 - 10/2004
11Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2013
9GemcitabineFDA Link
01/2021 - 07/2014
9EnzymesIBA
01/2019 - 08/2008
7Peptides (Polypeptides)IBA
02/2022 - 01/2016
5PolymersIBA
01/2020 - 01/2012
5Liposomes (Liposome)IBA
11/2014 - 07/2009
4LipidsIBA
01/2022 - 07/2009
4Oxygen (Dioxygen)IBA
10/2021 - 01/2016
4Drug CarriersIBA
01/2019 - 07/2014
4Folic Acid (Vitamin M)FDA LinkGeneric
11/2016 - 03/2013
4Biomarkers (Surrogate Marker)IBA
01/2016 - 01/2012
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
07/2014 - 07/2009
3Ethylene Glycol (Monoethylene Glycol)IBA
02/2022 - 01/2016
3N-end cysteine peptide tumor-homing peptideIBA
01/2022 - 03/2018
3poly(lactide) (polylactic acid)IBA
10/2021 - 01/2016
3LigandsIBA
10/2021 - 06/2013
3Biological ProductsIBA
11/2019 - 05/2010
3Culture MediaIBA
12/2012 - 01/2012
2IntegrinsIBA
02/2022 - 01/2022
2Estrogen ReceptorsIBA
10/2021 - 11/2020
2AminesIBA
12/2020 - 02/2019
2napabucasinIBA
10/2018 - 03/2018
2azobenzeneIBA
08/2018 - 01/2016
2Proteins (Proteins, Gene)FDA Link
03/2018 - 04/2014
2Histone Deacetylases (Histone Deacetylase)IBA
11/2016 - 11/2013
2Lipid NanoparticlesIBA
01/2016 - 11/2014
2Coloring Agents (Dyes)IBA
01/2016 - 09/2012
2Matrix Metalloproteinases (MMPs)IBA
04/2011 - 08/2008
1aspartic acid glycine arginineIBA
02/2022
1Dihydrotachysterol (AT 10)IBA
01/2022
1NeuropilinsIBA
01/2022
1Lipid Bilayers (Lipid Bilayer)IBA
01/2022
14-hydroxy-N-desmethyltamoxifenIBA
10/2021
1Selective Estrogen Receptor Modulators (SERM)IBA
10/2021
1TamoxifenFDA LinkGeneric
10/2021
1BuffersIBA
01/2021
1pyrrolidineIBA
12/2020
1polycarbonateIBA
12/2020
1AmidesIBA
12/2020
1Estradiol (Delestrogen)FDA LinkGeneric
11/2020
1Amino AcidsFDA Link
06/2020
1CollagenIBA
01/2020
1Phosphotransferases (Kinase)IBA
09/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2019
1CarbonatesIBA
02/2019
1HhAntag691IBA
02/2019
1Antineoplastic Agents (Antineoplastics)IBA
02/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Deoxycytidine KinaseIBA
01/2019
1Connective Tissue Growth FactorIBA
01/2019
1Reducing AgentsIBA
10/2018
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
08/2018
1AcidsIBA
03/2018
1Neuropilin-1IBA
03/2018
1CurcuminIBA
01/2017
1Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2017
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
01/2017
1AndrogensIBA
11/2016
1Docetaxel (Taxotere)FDA Link
11/2016
1AntigensIBA
11/2016
1mocetinostatIBA
11/2016
1Drug CombinationsIBA
03/2016
1Acridine OrangeIBA
03/2016
1Membrane LipidsIBA
01/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1N-(phenylcarbothiol)benzamideIBA
03/2015
1Small Interfering RNA (siRNA)IBA
11/2014
1DNA (Deoxyribonucleic Acid)IBA
11/2014
1VorinostatFDA Link
11/2013
1Histone Deacetylase InhibitorsIBA
11/2013
1DisintegrinsIBA
10/2013
1Trastuzumab (Herceptin)FDA Link
06/2013
1Receptor for Advanced Glycation End ProductsIBA
06/2013
1human ERBB2 proteinIBA
06/2013
1pyranineIBA
08/2011
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
08/2011

Therapy/Procedure

9Therapeutics
09/2021 - 01/2015
4Drug Therapy (Chemotherapy)
01/2020 - 03/2018
1Combination Drug Therapy (Combination Chemotherapy)
09/2019
1Radiotherapy
08/2018
1Intravenous Administration
07/2014